|
Tumor-Specific Zr-89 Immuno-PET Imaging in a Human Bladder Cancer Model
|
journal
|
March 2018 |
|
89Zr-DFO-AMG102 Immuno-PET to Determine Local Hepatocyte Growth Factor Protein Levels in Tumors for Enhanced Patient Selection
|
journal
|
March 2017 |
|
Synthesis and evaluation of bifunctional tetrahydroxamate chelators for labeling antibodies with 89 Zr for imaging with positron emission tomography
|
journal
|
March 2018 |
|
PET imaging in renal cancer
|
journal
|
May 2019 |
|
Treatment of iron overload in adults with continuous parenteral desferrioxamine
|
journal
|
December 1977 |
|
89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo
|
journal
|
July 2010 |
|
In vivo biodistribution and accumulation of 89Zr in mice
|
journal
|
July 2011 |
|
Octadentate Zirconium(IV)-Loaded Macrocycles with Varied Stoichiometry Assembled From Hydroxamic Acid Monomers using Metal-Templated Synthesis
|
journal
|
February 2017 |
|
The Role of 89Zr-Immuno-PET in Navigating and Derisking the Development of Biopharmaceuticals
|
journal
|
December 2020 |
|
Evaluation of the Tetrakis(3-Hydroxy-4-Pyridinone) Ligand THPN with Zirconium(IV): Thermodynamic Solution Studies, Bifunctionalization, and in Vivo Assessment of Macromolecular 89Zr-THPN-Conjugates
|
journal
|
October 2019 |
|
Chemical and biological properties of toxic metals and use of chelating agents for the pharmacological treatment of metal poisoning
|
journal
|
April 2010 |
|
Positron Emission Tomography/Computed Tomography with 89Zr-girentuximab Can Aid in Diagnostic Dilemmas of Clear Cell Renal Cell Carcinoma Suspicion
|
journal
|
September 2018 |
|
Addressing a Common Misconception: Ammonium Acetate as Neutral pH “Buffer” for Native Electrospray Mass Spectrometry
|
journal
|
July 2017 |
|
Di-macrocyclic terephthalamide ligands as chelators for the PET radionuclide zirconium-89
|
journal
|
January 2015 |
|
A solid phase-assisted approach for the facile synthesis of a highly water-soluble zirconium-89 chelator for radiopharmaceutical development
|
journal
|
January 2017 |
|
Comparison of analytical methods for antibody conjugates with application in nuclear imaging – Report from the trenches
|
journal
|
November 2021 |
|
Tripodal tris(hydroxypyridinone) ligands for immunoconjugate PET imaging with 89 Zr 4+ : comparison with desferrioxamine-B
|
journal
|
January 2015 |
|
Predicting the Thermodynamic Stability of Zirconium Radiotracers
|
journal
|
January 2020 |
|
Alternative Chelator for 89 Zr Radiopharmaceuticals: Radiolabeling and Evaluation of 3,4,3-(LI-1,2-HOPO)
|
journal
|
December 2013 |
|
PET Tracers Based on Zirconium-89
|
journal
|
April 2011 |
|
Production and Semi-Automated Processing of 89Zr Using a Commercially Available TRASIS MiniAiO Module
|
journal
|
June 2020 |
|
A Semi Rigid Novel Hydroxamate AMPED-Based Ligand for 89Zr PET Imaging
|
journal
|
September 2021 |
|
Standardized methods for the production of high specific-activity zirconium-89
|
journal
|
October 2009 |
|
Side-by-Side Comparison of Five Chelators for 89Zr-Labeling of Biomolecules: Investigation of Chemical/Radiochemical Properties and Complex Stability
|
journal
|
December 2021 |
|
Development and Characterization of Clinical-Grade 89 Zr-Trastuzumab for HER2/ neu ImmunoPET Imaging
|
journal
|
May 2009 |
|
[nat/89Zr][Zr(pypa)]: Thermodynamically Stable and Kinetically Inert Binary Nonadentate Complex for Radiopharmaceutical Applications
|
journal
|
November 2021 |
|
Design, Synthesis, and Evaluation of DFO-Em: A Modular Chelator with Octadentate Chelation for Optimal Zirconium-89 Radiochemistry
|
journal
|
December 2022 |
|
In Vitro and In Vivo Comparison of 3,2-HOPO Versus Deferoxamine-Based Chelation of Zirconium-89 to the Antimesothelin Antibody Anetumab
|
journal
|
May 2021 |
|
First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake
|
journal
|
August 2016 |
|
Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for 89Zr-immuno-PET
|
journal
|
August 2016 |
|
The Bioconjugation and Radiosynthesis of 89Zr-DFO-labeled Antibodies
|
journal
|
January 2015 |
|
A Phase I/II Study for Analytic Validation of 89 Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer
|
journal
|
July 2015 |
|
Novel Chelating Agents for Zirconium-89-Positron Emission Tomography (PET) Imaging: Synthesis, DFT Calculation, Radiolabeling, and In Vitro and In Vivo Complex Stability
|
journal
|
October 2022 |
|
PET and MRI of Metastatic Peritoneal and Pulmonary Colorectal Cancer in Mice with Human Epidermal Growth Factor Receptor 1–Targeted 89 Zr-Labeled Panitumumab
|
journal
|
January 2012 |
|
Trastuzumab-conjugated oxine-based ligand for [89Zr]Zr4+ immunoPET
|
journal
|
October 2022 |
|
Promising Performance of 4HMS, a New Zirconium-89 Octadendate Chelator
|
journal
|
May 2020 |
|
Toward Optimized 89Zr-Immuno-PET: Side-by-Side Comparison of [89Zr]Zr-DFO-, [89Zr]Zr-3,4,3-(LI-1,2-HOPO)- and [89Zr]Zr-DFO*-Cetuximab for Tumor Imaging: Which Chelator Is the Most Suitable?
|
journal
|
October 2022 |
|
Novel Bifunctional Cyclic Chelator for 89 Zr Labeling–Radiolabeling and Targeting Properties of RGD Conjugates
|
journal
|
April 2015 |
|
Current advances in ligand design for inorganic positron emission tomography tracers 68 Ga, 64 Cu, 89 Zr and 44 Sc
|
journal
|
January 2016 |
|
Study of 89Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non–Small Cell Lung Cancer
|
journal
|
July 2021 |
|
From molecules to solids with the DMol3 approach
|
journal
|
November 2000 |
|
Modular Strategy for the Construction of Radiometalated Antibodies for Positron Emission Tomography Based on Inverse Electron Demand Diels–Alder Click Chemistry
|
journal
|
October 2011 |
|
The Race for Hydroxamate-Based Zirconium-89 Chelators
|
journal
|
September 2021 |
|
A High-Denticity Chelator Based on Desferrioxamine for Enhanced Coordination of Zirconium-89
|
journal
|
July 2020 |
|
89Zr-Labeled Domain II-Specific scFv-Fc ImmunoPET Probe for Imaging Epidermal Growth Factor Receptor In Vivo
|
journal
|
February 2021 |
|
Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
|
journal
|
March 2010 |
|
Multifunctional Desferrichrome Analogues as Versatile 89Zr(IV) Chelators for ImmunoPET Probe Development
|
journal
|
July 2017 |
|
Preparation and evaluation of 89Zr-Zevalin for monitoring of 90Y-Zevalin biodistribution with positron emission tomography
|
journal
|
July 2006 |
|
Performance of Immuno–Positron Emission Tomography with Zirconium-89-Labeled Chimeric Monoclonal Antibody U36 in the Detection of Lymph Node Metastases in Head and Neck Cancer Patients
|
journal
|
April 2006 |
|
Scaling-down antibody radiolabeling reactions with zirconium-89
|
journal
|
January 2016 |
|
Thermodynamic Stability and Speciation of Ga(III) and Zr(IV) Complexes with High-Denticity Hydroxamate Chelators
|
journal
|
August 2021 |
|
Zirconium tetraazamacrocycle complexes display extraordinary stability and provide a new strategy for zirconium-89-based radiopharmaceutical development
|
journal
|
January 2017 |
|
Production of Zr-89 using sputtered yttrium coin targets
|
journal
|
July 2017 |
|
What a Difference a Carbon Makes: H4octapa vs H4C3octapa, Ligands for In-111 and Lu-177 Radiochemistry
|
journal
|
September 2014 |
|
XAS-Collect : a computer program for X-ray absorption spectroscopic data acquisition
|
journal
|
July 2000 |
|
Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?
|
journal
|
May 2016 |
|
Synthesis and evaluation of Diaza-Crown Ether-Backboned chelator containing hydroxamate groups for Zr-89 chelation chemistry
|
journal
|
September 2022 |
|
Structural Characterization of the Solution Chemistry of Zirconium(IV) Desferrioxamine: A Coordination Sphere Completed by Hydroxides
|
journal
|
November 2020 |
|
A Systematic Evaluation of Antibody Modification and 89Zr-Radiolabeling for Optimized Immuno-PET
|
journal
|
March 2020 |
|
Evaluation of DFO-HOPO as an octadentate chelator for zirconium-89
|
journal
|
January 2017 |
|
Recent Advances in Zirconium-89 Chelator Development
|
journal
|
March 2018 |
|
Applying PET to Broaden the Diagnostic Utility of the Clinically Validated CA19.9 Serum Biomarker for Oncology
|
journal
|
September 2013 |
|
89Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2–Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2–Negative Primary Breast Cancer
|
journal
|
December 2017 |
|
COSMO: a new approach to dielectric screening in solvents with explicit expressions for the screening energy and its gradient
|
journal
|
January 1993 |
|
An all‐electron numerical method for solving the local density functional for polyatomic molecules
|
journal
|
January 1990 |
|
Investigation of Zr( iv ) and 89 Zr( iv ) complexation with hydroxamates: progress towards designing a better chelator than desferrioxamine B for immuno-PET imaging
|
journal
|
January 2013 |
|
Rational Design, Development, and Stability Assessment of a Macrocyclic Four‐Hydroxamate‐Bearing Bifunctional Chelating Agent for 89Zr
|
journal
|
September 2017 |
|
p -SCN-Bn-HOPO: A Superior Bifunctional Chelator for 89 Zr ImmunoPET
|
journal
|
November 2015 |
|
The Molybdenum Site of Sulfite Oxidase: A Comparison of Wild-Type and the Cysteine 207 to Serine Mutant Using X-ray Absorption Spectroscopy
|
journal
|
January 1996 |
|
Macrocycle-Based Hydroxamate Ligands for Complexation and Immunoconjugation of 89 Zirconium for Positron Emission Tomography (PET) Imaging
|
journal
|
January 2016 |
|
Measuring the Pharmacodynamic Effects of a Novel Hsp90 Inhibitor on HER2/neu Expression in Mice Using 89Zr-DFO-Trastuzumab
|
journal
|
January 2010 |
|
Positron-Emission Tomography of HER2-Positive Breast Cancer Xenografts in Mice with 89Zr-Labeled Trastuzumab-DM1: A Comparison with 89Zr-Labeled Trastuzumab
|
journal
|
June 2018 |
|
An octadentate bifunctional chelating agent for the development of stable zirconium-89 based molecular imaging probes
|
journal
|
January 2014 |
|
A desferrioxamine B squaramide ester for the incorporation of zirconium-89 into antibodies
|
journal
|
January 2016 |
|
Development and in vitro evaluation of new bifunctional 89Zr-chelators based on the 6-amino-1,4-diazepane scaffold for immuno-PET applications
|
journal
|
November 2021 |
|
X-ray Absorption Spectroscopy Investigations of Copper(II) Coordination in the Human Amyloid β Peptide
|
journal
|
April 2019 |
|
Generalized Gradient Approximation Made Simple
|
journal
|
October 1996 |
|
Rational Design, Synthesis, and Evaluation of Tetrahydroxamic Acid Chelators for Stable Complexation of Zirconium(IV)
|
journal
|
April 2014 |
|
Evaluation of a 3-hydroxypyridin-2-one (2,3-HOPO) Based Macrocyclic Chelator for 89 Zr 4+ and Its Use for ImmunoPET Imaging of HER2 Positive Model of Ovarian Carcinoma in Mice
|
journal
|
January 2016 |
|
A new tetrapodal 3-hydroxy-4-pyridinone ligand for complexation of 89zirconium for positron emission tomography (PET) imaging
|
journal
|
January 2017 |
|
Matching chelators to radiometals for radiopharmaceuticals
|
journal
|
January 2014 |
|
Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinical 89Zr-immuno-PET
|
journal
|
September 2020 |
|
M11-L: A Local Density Functional That Provides Improved Accuracy for Electronic Structure Calculations in Chemistry and Physics
|
journal
|
December 2011 |
|
Propylene Cross-Bridged Macrocyclic Bifunctional Chelator: A New Design for Facile Bioconjugation and Robust 64Cu Complex Stability
|
journal
|
August 2014 |
|
Incorporation of solvent effects into density functional calculations of molecular energies and geometries
|
journal
|
December 1995 |